Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001213900-20-000178
Filing Date
2020-01-03
Accepted
2020-01-03 17:18:25
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1090855
2 GRAPHIC image_001.jpg GRAPHIC 6917
3 GRAPHIC image_002.jpg GRAPHIC 60022
4 GRAPHIC image_003.jpg GRAPHIC 94687
5 GRAPHIC image_004.jpg GRAPHIC 74524
  Complete submission text file 0001213900-20-000178.txt   1417704
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-02863 | Film No.: 20506766
SIC: 2834 Pharmaceutical Preparations